KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ: 307750)
South Korea
· Delayed Price · Currency is KRW
4,225.00
+110.00 (2.67%)
Sep 12, 2024, 3:19 PM KST
KUKJEON PHARMACEUTICAL Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 11, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 201,920 | 306,192 | 324,839 | 537,308 |
| Market Cap Growth | -13.53% | -5.74% | -39.54% | - |
| Enterprise Value | 224,430 | 319,290 | 284,635 | - |
| Last Close Price | 4115.00 | 6240.00 | 6609.15 | 10932.05 |
| PE Ratio | 63.12 | 63.67 | 582.25 | 120.13 |
| PS Ratio | 1.52 | 2.51 | 3.13 | 6.30 |
| PB Ratio | 2.04 | 3.14 | 3.52 | 6.46 |
| P/FCF Ratio | -29.78 | -6.92 | -11.09 | -72.94 |
| P/OCF Ratio | 29.51 | -886.35 | -53.97 | 176.63 |
| EV/Sales Ratio | 1.68 | 2.62 | 2.74 | - |
| EV/EBITDA Ratio | 28.75 | 33.11 | 57.72 | - |
| EV/EBIT Ratio | 70.17 | 49.05 | 81.60 | - |
| EV/FCF Ratio | -26.97 | -7.21 | -9.71 | - |
| Debt / Equity Ratio | 0.74 | 0.81 | 0.64 | 0.09 |
| Debt / EBITDA Ratio | 9.53 | 8.17 | 12.03 | 1.09 |
| Debt / FCF Ratio | -8.92 | -1.78 | -2.02 | -1.07 |
| Asset Turnover | 0.62 | 0.58 | 0.68 | - |
| Inventory Turnover | 4.00 | 4.05 | 4.62 | - |
| Quick Ratio | 0.91 | 0.94 | 1.67 | 2.72 |
| Current Ratio | 1.20 | 1.24 | 2.02 | 3.52 |
| Return on Equity (ROE) | 4.77% | 4.94% | 10.12% | - |
| Return on Assets (ROA) | 0.92% | 1.93% | 1.44% | - |
| Return on Capital (ROIC) | 1.19% | 2.48% | 1.80% | - |
| Earnings Yield | 1.58% | 1.58% | 2.75% | 0.75% |
| FCF Yield | -4.12% | -14.46% | -9.02% | -1.37% |
| Dividend Yield | 0.24% | 0.16% | - | - |
| Payout Ratio | 9.16% | - | 5.48% | - |
| Buyback Yield / Dilution | -5.99% | 4.23% | -16.16% | - |
| Total Shareholder Return | -5.74% | 4.39% | -16.16% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.